"Robotic surgery is a major step forward in surgery, with many positive effects on treatment outcomes, hospitalisation duration, sick leave and total financial costs. Surgical procedures are minimised by the use of state-of-the-art technology, improving treatment outcomes," Beroš said.
The robotic surgery system will enable minimally invasive procedures and improve the treatment of patients suffering from prostate cancer, colorectal cancer, cervical cancer, lung cancer and other malignant diseases.
The system was installed on 19 June, and 16 surgeries have been successfully performed since.
About 300 prostate operations, 200 kidney operations, 300 abdominal operations and 200 gynaecological operations are expected to be performed annually using the Da Vinci system.
"By combining prevention with state-of-the-art treatment techniques, I truly believe that we will improve our social system and ultimately achieve better treatment outcomes, and that we will move up from the bottom of the European Union rankings on the success of oncology treatment," said Beroš.